Mary T. Szela

Mary T. Szela

DirectoratKura Oncology· In proxies 2023–2025

Mary T. Szela sits on 11 public boards.

Boards1

  • Kura OncologyDirector · 7 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Kura OncologyPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -5%
  2. Averin Capital Acquisition Corp.Public company · Less than 1 yr
    • Director2026 – Present · Less than 1 yrNo stock prices for these years
  3. Absci CorporationPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  4. Senda Biosciences, Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  5. Omega Therapeutics, Inc.Public company · 7 yr
    • Director2019 – Present · 7 yrNo stock prices for these years
  6. Sail Biomedicines, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Prometheus Biosciences, Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  8. Coherus Oncology, Inc.Public company
    • Director? – PresentNo stock prices for these years
  9. Alimera Sciences, Inc.Public company · 3 yr
    • Director2018 – 2021 · 3 yrNo stock prices for these years
  10. Coherus BioSciences, Inc.Public company · 7 yr
    • Director2014 – 2021 · 7 yrNo stock prices for these years
  11. Novelion Therapeutics Inc.Public company
    • Director? – 2017No stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?